Suppr超能文献

相似文献

1
Impact of COVID-19 on Treatment in Patients with Renal Cell Carcinoma.
Arch Razi Inst. 2024 Oct 31;79(5):1091-1097. doi: 10.32592/ARI.2024.79.5.1091. eCollection 2024 Oct.
3
COVID-19 and financial toxicity in patients with renal cell carcinoma.
World J Urol. 2021 Jul;39(7):2559-2565. doi: 10.1007/s00345-020-03476-6. Epub 2020 Oct 22.
5
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
6
COVID-19 in Patients With Renal Cell Carcinoma in the Russian Federation.
Clin Genitourin Cancer. 2021 Apr;19(2):e69-e71. doi: 10.1016/j.clgc.2020.07.007. Epub 2020 Jul 16.
7
COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer.
Eur Urol Focus. 2020 Sep 15;6(5):1086-1096. doi: 10.1016/j.euf.2020.06.002. Epub 2020 Jun 9.
8
Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond.
Urol Oncol. 2021 May;39(5):247-257. doi: 10.1016/j.urolonc.2020.10.012. Epub 2020 Oct 20.
10
Role of cytoreductive nephrectomy in renal cell carcinoma.
Future Oncol. 2009 Aug;5(6):859-69. doi: 10.2217/fon.09.52.

本文引用的文献

1
COVID-19 pandemic: A challenge to a child with cancer.
Pediatr Blood Cancer. 2020 Sep;67(9):e28512. doi: 10.1002/pbc.28512. Epub 2020 Jul 7.
2
Safe Endourology Procedure Using a C-Arm Drape During Coronavirus 2019 Disease Times.
J Endourol. 2020 Aug;34(8):887-888. doi: 10.1089/end.2020.0607.
3
Advanced renal cell carcinoma and COVID-19 - a personal perspective.
Nat Rev Urol. 2020 Aug;17(8):425-427. doi: 10.1038/s41585-020-0345-5.
4
Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario.
Indian J Cancer. 2020 Apr-Jun;57(2):129-138. doi: 10.4103/ijc.IJC_356_20.
5
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
6
A novel coronavirus outbreak of global health concern.
Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24.
7
Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?
Eur Urol Oncol. 2019 Jul;2(4):365-378. doi: 10.1016/j.euo.2019.04.007. Epub 2019 May 18.
8
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16.
9
Cytoreductive nephrectomy: questions remain after CARMENA.
Nat Rev Urol. 2018 Sep;15(9):530-532. doi: 10.1038/s41585-018-0064-3.
10
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验